Stock info Straumann | Filter  Basic-Info

Straumann

Straumann's core business is the health care eq. & services sector. The global health care companies gained over the past 10 years on average 102 percent. As from 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The past year was a relatively good year for Straumann investors

Over the period from December 2015 till December 2016 the stock gained around 30 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 136 percent. Straumann's revenues between 2011 and 2015 were quite stable and moved between 686,25 million CHFF and 798,6 million CHFF. Straumann's net results between 2011 and 2015 were relatively stable and moved between 70,86 million CHFF and 69,66 million CHFF.

Over the past 5 years the Swiss company paid out dividends. Over the past 5 years the stock delivered an average dividend return of 19 percent.

At the end of 2015 Straumann employed at around 2387 thousand people.

Straumann' balance mostly financed with equity

Last year the balance sheet of the Swiss company was worth 1,05 billion CHFF. The total debt of the health care company was at the end of 2015 441,33 million CHFF, which equals around 42,18 percent of the total balance sheet. As per the end of 2015 Straumann's price/earnings-ratio equaled 57. So investors paid for 1 stock 57 times the earnings per share of 2015. Based on it's price/earnings-ratio and dividend yield the Swiss stock can be seen as a value stock.

At the end of 2015 the Swiss company's market capitalization equaled around 4,75 billion CHFF. At the end of 2015 the Swiss company had around 15,65 million stocks listed.

All Straumann's financial reports are located here. More information about Straumann can be found it's website. .